Resource utilization and costs of age-related macular degeneration

Michael Halpern, Jordana K. Schmier, David Covert, Krithika Venkataraman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Data were analyzed from the 1999-2001 Medicare Beneficiary Encrypted Files for patients with age-related macular degeneration (AMD), an ophthalmic condition characterized by central vision loss. Classifying AMD subtype by International Classification of Diseases, Ninth Revision, Clinical Modifications (ICD-9-CM) (Centers for Disease Control and Prevention, 2003) code, resource utilization rates increased with disease progression. Individuals with more severe disease (wet only or wet and dry AMD) had greater costs than did those with less severe disease (drusen only or dry only). Costs among patients with wet disease increased yearly at rates exceeding inflation, possibly due in part to increased rates of treatment with photodynamic therapy among these individuals and the aging of the population.

Original languageEnglish (US)
Pages (from-to)37-47
Number of pages11
JournalHealth Care Financing Review
Volume27
Issue number3
StatePublished - Mar 2006
Externally publishedYes

Fingerprint

Macular Degeneration
utilization
International Classification of Diseases
Disease
Costs and Cost Analysis
costs
resources
Economic Inflation
Photochemotherapy
Centers for Disease Control and Prevention (U.S.)
Medicare
Disease Progression
inflation
Population
Therapeutics

ASJC Scopus subject areas

  • Nursing(all)
  • Health(social science)
  • Health Professions(all)

Cite this

Halpern, M., Schmier, J. K., Covert, D., & Venkataraman, K. (2006). Resource utilization and costs of age-related macular degeneration. Health Care Financing Review, 27(3), 37-47.

Resource utilization and costs of age-related macular degeneration. / Halpern, Michael; Schmier, Jordana K.; Covert, David; Venkataraman, Krithika.

In: Health Care Financing Review, Vol. 27, No. 3, 03.2006, p. 37-47.

Research output: Contribution to journalArticle

Halpern, M, Schmier, JK, Covert, D & Venkataraman, K 2006, 'Resource utilization and costs of age-related macular degeneration', Health Care Financing Review, vol. 27, no. 3, pp. 37-47.
Halpern, Michael ; Schmier, Jordana K. ; Covert, David ; Venkataraman, Krithika. / Resource utilization and costs of age-related macular degeneration. In: Health Care Financing Review. 2006 ; Vol. 27, No. 3. pp. 37-47.
@article{fa6ca1c4ba31441ca32bd64da49c1d03,
title = "Resource utilization and costs of age-related macular degeneration",
abstract = "Data were analyzed from the 1999-2001 Medicare Beneficiary Encrypted Files for patients with age-related macular degeneration (AMD), an ophthalmic condition characterized by central vision loss. Classifying AMD subtype by International Classification of Diseases, Ninth Revision, Clinical Modifications (ICD-9-CM) (Centers for Disease Control and Prevention, 2003) code, resource utilization rates increased with disease progression. Individuals with more severe disease (wet only or wet and dry AMD) had greater costs than did those with less severe disease (drusen only or dry only). Costs among patients with wet disease increased yearly at rates exceeding inflation, possibly due in part to increased rates of treatment with photodynamic therapy among these individuals and the aging of the population.",
author = "Michael Halpern and Schmier, {Jordana K.} and David Covert and Krithika Venkataraman",
year = "2006",
month = "3",
language = "English (US)",
volume = "27",
pages = "37--47",
journal = "Health Care Financing Review",
issn = "2159-0354",
publisher = "Centers for Medicare & Medicaid Services' Office of Research, Development & Information",
number = "3",

}

TY - JOUR

T1 - Resource utilization and costs of age-related macular degeneration

AU - Halpern, Michael

AU - Schmier, Jordana K.

AU - Covert, David

AU - Venkataraman, Krithika

PY - 2006/3

Y1 - 2006/3

N2 - Data were analyzed from the 1999-2001 Medicare Beneficiary Encrypted Files for patients with age-related macular degeneration (AMD), an ophthalmic condition characterized by central vision loss. Classifying AMD subtype by International Classification of Diseases, Ninth Revision, Clinical Modifications (ICD-9-CM) (Centers for Disease Control and Prevention, 2003) code, resource utilization rates increased with disease progression. Individuals with more severe disease (wet only or wet and dry AMD) had greater costs than did those with less severe disease (drusen only or dry only). Costs among patients with wet disease increased yearly at rates exceeding inflation, possibly due in part to increased rates of treatment with photodynamic therapy among these individuals and the aging of the population.

AB - Data were analyzed from the 1999-2001 Medicare Beneficiary Encrypted Files for patients with age-related macular degeneration (AMD), an ophthalmic condition characterized by central vision loss. Classifying AMD subtype by International Classification of Diseases, Ninth Revision, Clinical Modifications (ICD-9-CM) (Centers for Disease Control and Prevention, 2003) code, resource utilization rates increased with disease progression. Individuals with more severe disease (wet only or wet and dry AMD) had greater costs than did those with less severe disease (drusen only or dry only). Costs among patients with wet disease increased yearly at rates exceeding inflation, possibly due in part to increased rates of treatment with photodynamic therapy among these individuals and the aging of the population.

UR - http://www.scopus.com/inward/record.url?scp=33744938673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744938673&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 37

EP - 47

JO - Health Care Financing Review

JF - Health Care Financing Review

SN - 2159-0354

IS - 3

ER -